Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands.

ABSTRACT:

Background

Extracorporeal life support (ECLS) is used to support the cardiorespiratory function in case of severe cardiac and/or respiratory failure in critically ill patients. According to the ELSO guidelines ECLS should be considered when estimated mortality risk approximates 80%. ECLS seems an efficient therapy in terms of survival benefit, but no undisputed evidence is delivered yet. The aim of the study is to assess the health-related quality of life after ECLS treatment and its cost effectiveness.

Methods

We will perform a prospective observational cohort study. All adult patients who receive ECLS in the participating centers will be included. Exclusion criteria are patients in whom the ECLS is only used to bridge a procedure (like a high risk percutaneous coronary int

SUBMITTER: Oude Lansink-Hartgring A 

PROVIDER: S-EPMC5845153 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature